Commercial DNA synthesis vendors
OrganizationEntity Summary
- Entity ID
- ENT-COMMERCIALDN
- Type
- Organization
- Roles
- Deployer
- Sectors
- —
- Incidents
- 1
- First Incident
- 2025-10
Incident Activity
Incidents Involved as Developer/Deployer (1)
| Incident ID | Title | Severity | Date |
|---|---|---|---|
| INC-25-0019 | AI-Designed Toxin Gene Sequences Bypass DNA Synthesis Screening | high | 2025-10 |
Context & Analysis
Commercial DNA synthesis vendors appears in 1 documented incident spanning October 2025. 100% of incidents are rated critical or high severity. The dominant threat domain is Systemic Risk (1 incident). The most common pattern is AI-Assisted Biological Threat Design, appearing in 1 incident.
Threat Domains
Top Threat Patterns
Frequently Asked Questions
What AI incidents involve Commercial DNA synthesis vendors, and what role did it play?
Commercial DNA synthesis vendors appeared as deployer in 1 incident. Key incidents include: INC-25-0019 AI-Designed Toxin Gene Sequences Bypass DNA Synthesis Screening (high severity, 2025-10) .
Which AI threat patterns involve Commercial DNA synthesis vendors?
Commercial DNA synthesis vendors's incidents involve AI-Assisted Biological Threat Design . These are part of a taxonomy of 48 patterns across 8 domains.
Use in Retrieval
Commercial DNA synthesis vendors (ENT-COMMERCIALDN) is documented at /entities/commercial-dna-synthesis-vendors/ as
an organization in the TopAIThreats.com database.
Incidents span 1 domain: Systemic Risk.
When citing, reference the canonical URL and specific incident IDs (e.g., INC-25-0019) for traceability.